{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T03:03:00Z","timestamp":1794193380694,"version":"4.8.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Deanship of Scientific Research (DSR) at King Abdulaziz University (KAU), Jeddah, Saudi Arabia","award":["GPIP: 1674-156-2024"],"award-info":[{"award-number":["GPIP: 1674-156-2024"]}]},{"name":"Deanship of Scientific Research (DSR) at King Abdulaziz University (KAU), Jeddah, Saudi Arabia","award":["GPIP: 1674-156-2024"],"award-info":[{"award-number":["GPIP: 1674-156-2024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98645-1","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T03:35:51Z","timestamp":1745811351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Synthesis, characterization and bio-evaluation of novel series of pyrazoline derivatives as potential antifungal agents"],"prefix":"10.1038","volume":"15","author":[{"given":"Chandra Shekhar","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suriya Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Kishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minaxi B.","family":"Lohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varish","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rahman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqbal","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"98645_CR1","doi-asserted-by":"publisher","first-page":"14170","DOI":"10.1039\/D0RA01378A","volume":"10","author":"M Henary","year":"2020","unstructured":"Henary, M. et al. Benefits and applications of microwave-assisted synthesis of nitrogen containing heterocycles in medicinal chemistry. RSC Adv. 10, 14170\u201314197 (2020).","journal-title":"RSC Adv."},{"key":"98645_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jmgm.2018.02.013","volume":"81","author":"I Azad","year":"2018","unstructured":"Azad, I., Nasibullah, M., Khan, T., Hassan, F. & Akhter, Y. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents. J. Mol. Graph Model. 81, 211\u2013228 (2018).","journal-title":"J. Mol. Graph Model."},{"key":"98645_CR3","doi-asserted-by":"publisher","first-page":"8117","DOI":"10.3390\/ijms23158117","volume":"23","author":"O Ebenezer","year":"2022","unstructured":"Ebenezer, O. et al. An overview of the biological evaluation of selected nitrogen-containing heterocycle medicinal chemistry compounds. Int. J. Mol. Sci. 2022. 23, 8117 (2022).","journal-title":"Int. J. Mol. Sci. 2022"},{"key":"98645_CR4","doi-asserted-by":"crossref","unstructured":"Dhiman, P., Malik, N. & Khatkar, A. Docking-Related survey on Natural-Product-Based new monoamine oxidase inhibitors and their therapeutic potential. Comb. Chem. High. Throughput Screen. 20, (2017).","DOI":"10.2174\/1386207320666170414102814"},{"key":"98645_CR5","first-page":"614","volume":"122","author":"\u00c1 Ca\u00f1ete-Molina","year":"2018","unstructured":"Ca\u00f1ete-Molina, \u00c1. et al. Bromination-a versatile tool for drugs optimization. Medical-Surgical J. 122, 614\u2013626 (2018).","journal-title":"Medical-Surgical J."},{"key":"98645_CR6","doi-asserted-by":"publisher","first-page":"101326","DOI":"10.1016\/j.rechem.2024.101326","volume":"7","author":"S Yadav","year":"2024","unstructured":"Yadav, S. Recent advances in the synthesis of pyrazoline derivatives from chalcones as potent pharmacological agents: A comprehensive review. Results Chem. 7, 101326 (2024).","journal-title":"Results Chem."},{"key":"98645_CR7","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1021\/jm500206r","volume":"57","author":"A Casimiro-Garcia","year":"2014","unstructured":"Casimiro-Garcia, A. et al. Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5- dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist. J. Med. Chem. 57, 4273\u20134288 (2014).","journal-title":"J. Med. Chem."},{"key":"98645_CR8","doi-asserted-by":"crossref","unstructured":"Mantzanidou, M. & Pontiki, E. & Hadjipavlou-Litina, D. Pyrazoles and pyrazolines as anti-inflammatory agents. Molecules 26, 3439 (2021).","DOI":"10.3390\/molecules26113439"},{"key":"98645_CR9","doi-asserted-by":"publisher","first-page":"116401","DOI":"10.1016\/j.bmc.2021.116401","volume":"48","author":"M Payne","year":"2021","unstructured":"Payne, M. et al. Synthesis and biological evaluation of 3,5-substituted pyrazoles as possible antibacterial agents. Bioorg. Med. Chem. 48, 116401 (2021).","journal-title":"Bioorg. Med. Chem."},{"key":"98645_CR10","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1134\/S1070363219070028","volume":"89","author":"OA Nurkenov","year":"2019","unstructured":"Nurkenov, O. A. et al. Synthesis, structure, and anti-inflammatory activity of functionally substituted chalcones and their derivatives. Russ J. Gen. Chem. 89, 1360\u20131367 (2019).","journal-title":"Russ J. Gen. Chem."},{"key":"98645_CR11","doi-asserted-by":"crossref","unstructured":"Kumar, L. et al. Pyrazoline tethered 1, 2, 3-triazoles: Synthesis, antimicrobial evaluation and in silico studies. Journal of Molecular Structure. 1246, 131154 (2021).","DOI":"10.1016\/j.molstruc.2021.131154"},{"key":"98645_CR12","doi-asserted-by":"crossref","unstructured":"Kumar, L. et al. Synthesis, characterization, \u03b1-glucosidase inhibition and molecular modeling studies of some pyrazoline-1H-1, 2, 3-triazole hybrids. Journal of Molecular Structure. 1216, 128253 (2020)","DOI":"10.1016\/j.molstruc.2020.128253"},{"key":"98645_CR13","doi-asserted-by":"crossref","unstructured":"Rasal, N. K., Sonawane, B. & Jagtap, S. V. R. Synthesis, characterization, and biological study of 3-Trifluoromethylpyrazole tethered Chalcone\u2010Pyrrole and Pyrazoline\u2010Pyrrole derivatives. Chemistry & Biodiversity. 18, e2100504 (2021).","DOI":"10.1002\/cbdv.202100504"},{"key":"98645_CR14","first-page":"3264","volume":"26","author":"AS Nair","year":"2021","unstructured":"Nair, A. S. et al. Development of halogenated pyrazolines as selective monoamine oxidase-B inhibitors: Deciphering via molecular dynamics approach. Mol. 2021. 26, 3264 (2021).","journal-title":"Mol. 2021"},{"key":"98645_CR15","doi-asserted-by":"crossref","unstructured":"Kumar, A. et al. Synthesis, antidiabetic evaluation and bioisosteric modification of quinoline incorporated 2-pyrazoline derivatives. Indian J. Pharm. Educ. Res. 55, 574\u2013580 (2021).","DOI":"10.5530\/ijper.55.2.96"},{"key":"98645_CR16","unstructured":"Pharm Sci, P. J. et al. Synthesis, molecular Docking and anti-diabetic studies of novel benzimidazole-pyrazoline hybrid molecules. 33, 847\u2013854 (2020)."},{"key":"98645_CR17","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1080\/10406638.2020.1821231","volume":"42","author":"HN Akolkar","year":"2022","unstructured":"Akolkar, H. N. et al. Design, synthesis and biological evaluation of novel furan & thiophene containing pyrazolyl pyrazolines as antimalarial agents. Polycycl. Aromat. Compd. 42, 1959\u20131971 (2022).","journal-title":"Polycycl. Aromat. Compd."},{"key":"98645_CR18","doi-asserted-by":"crossref","unstructured":"\u00c7elik, G., Arslan, T., \u015eent\u00fcrk, M., der Pharmazie, D. E. A. & \u015eent\u00fcrk, M. undefined. Synthesis and characterization of some new pyrazolines and their inhibitory potencies against carbonic anhydrases. Archiv der Pharmazie. 353, 1900292 (2020).","DOI":"10.1002\/ardp.201900292"},{"key":"98645_CR19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.bmcl.2014.01.045","volume":"24","author":"E Kamogawa","year":"2014","unstructured":"Kamogawa, E. & Sueishi, Y. A multiple free-radical scavenging (MULTIS) study on the antioxidant capacity of a neuroprotective drug, Edaravone as compared with uric acid, glutathione, and trolox. Bioorg. Med. Chem. Lett. 24, 1376\u20131379 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"98645_CR20","unstructured":"Beebany, S. et al. Preparation and identification of new 1,4-bis (5,3-substituted-2,3-dihydro-1H-pyrazole-1-yl) Buta-1,4-Dione derivatives with their antibacterial effect evaluation. Chemical Methodologies. 7, 123\u2013136 (2023)."},{"key":"98645_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/2211352517666191022103831","volume":"18","author":"H Kumar","year":"2019","unstructured":"Kumar, H., Bansal, K. K. & Goyal, A. Synthetic methods and antimicrobial perspective of pyrazole derivatives: an insight. Anti-Infective Agents. 18, 207\u2013223 (2019).","journal-title":"Anti-Infective Agents"},{"key":"98645_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4155\/fmc-2020-0052","volume":"13","author":"H Martin","year":"2021","unstructured":"Martin, H., Kavanagh, K. & Velasco-Torrijos, T. Targeting adhesion in fungal pathogen Candida albicans. Future Med. Chem. 13, 313\u2013334 (2021).","journal-title":"Future Med. Chem."},{"key":"98645_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/10629360410001665839","volume":"15","author":"TW Schultz","year":"2004","unstructured":"Schultz, T. W. & Yarbrough, J. W. Trends in structure\u2013toxicity relationships for carbonyl-containing \u03b1,\u03b2-unsaturated compounds. SAR QSAR Environ. Res. 15, 139\u2013146 (2004).","journal-title":"SAR QSAR Environ. Res."},{"key":"98645_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.24845\/ijfac.v8.i2.88","volume":"8","author":"S Susilawati","year":"2023","unstructured":"Susilawati, S., Anwar, C., Saleh, I. & Salni, S. Flavonoid as anti-Candida agents. IJFAC (Indonesian J. Fundam Appl. Chem. 8, 88\u201397 (2023).","journal-title":"IJFAC (Indonesian J. Fundam Appl. Chem."},{"key":"98645_CR25","doi-asserted-by":"crossref","unstructured":"Yadav, C. S. et al. Exploring the therapeutic potential of Chalcones in oncology: A comprehensive review. Curr. Bioact Compd. 20, 12\u201347 (2024).","DOI":"10.2174\/0115734072266590231023094928"},{"key":"98645_CR26","doi-asserted-by":"publisher","first-page":"9974","DOI":"10.1002\/slct.202002278","volume":"5","author":"S Farooq","year":"2020","unstructured":"Farooq, S. & Ngaini, Z. Synthesis, molecular docking and antimicrobial activity of \u0391, \u03b2-unsaturated ketone exchange moiety for chalcone and pyrazoline derivatives. ChemistrySelect 5, 9974\u20139979 (2020).","journal-title":"ChemistrySelect"},{"key":"98645_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ejmech.2017.03.016","volume":"131","author":"J Ram\u00edrez\u2013Prada","year":"2017","unstructured":"Ram\u00edrez\u2013Prada, J. et al. Synthesis of novel quinoline\u2013based 4,5\u2013dihydro\u20131H\u2013pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents. Eur. J. Med. Chem. 131, 237\u2013254 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"98645_CR28","first-page":"831","volume":"18","author":"S Kumar","year":"2022","unstructured":"Kumar, S., Gupta, S., Rani, V. & Sharma, P. Pyrazole containing anti-HIV agents: an update. Med. Chem. (Los Angeles). 18, 831\u2013846 (2022).","journal-title":"Med. Chem. (Los Angeles)"},{"key":"98645_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ejmech.2019.07.034","volume":"180","author":"S Zhao","year":"2019","unstructured":"Zhao, S., Pi, C., Ye, Y., Zhao, L. & Wei, Y. Recent advances of analogues of curcumin for treatment of cancer. Eur. J. Med. Chem. 180, 524\u2013535 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"98645_CR30","doi-asserted-by":"crossref","unstructured":"Alex, J. & Kumar, R. 4,5-Dihydro-1H-pyrazole: an indispensable scaffold. Journal of enzyme inhibition and medicinal chemistry. 29, 427\u2013442 (2014).","DOI":"10.3109\/14756366.2013.795956"},{"key":"98645_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejps.2013.09.019","volume":"51","author":"M Goodarzi","year":"2014","unstructured":"Goodarzi, M., Saeys, W., De Araujo, M. C. U., Galv\u00e3o, R. K. H. & Vander Heyden, Y. Binary classification of chalcone derivatives with LDA or KNN based on their antileishmanial activity and molecular descriptors selected using the successive projections algorithm feature-selection technique. Eur. J. Pharm. Sci. 51, 189\u2013195 (2014).","journal-title":"Eur. J. Pharm. Sci."},{"key":"98645_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.molstruc.2013.12.083","volume":"1061","author":"B Chen","year":"2014","unstructured":"Chen, B., Zhu, Z., Chen, M., Dong, W. & Li, Z. Three-dimensional quantitative structure\u2013activity relationship study on antioxidant capacity of curcumin analogues. J. Mol. Struct. 1061, 134\u2013139 (2014).","journal-title":"J. Mol. Struct."},{"key":"98645_CR33","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s12272-013-0216-1","volume":"36","author":"ZY Du","year":"2013","unstructured":"Du, Z. Y. et al. Anti-proliferative, anti-inflammatory and antioxidant effects of curcumin analogue A2. Arch. Pharm. Res. 36, 1204\u20131210 (2013).","journal-title":"Arch. Pharm. Res."},{"key":"98645_CR34","first-page":"897","volume":"9","author":"S Bukhari","year":"2013","unstructured":"Bukhari, S., Franzblau, S., Jantan, I. & Jasamai, M. Current prospects of synthetic curcumin analogs and chalcone derivatives against Mycobacterium Tuberculosis. Med. Chem. (Los Angeles). 9, 897\u2013903 (2013).","journal-title":"Med. Chem. (Los Angeles)"},{"key":"98645_CR35","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1021\/acs.jmedchem.6b00276","volume":"59","author":"HL Qin","year":"2016","unstructured":"Qin, H. L. et al. Synthesis of \u03b1,\u03b2-unsaturated carbonyl-based compounds, oxime and oxime ether analogs as potential anticancer agents for overcoming cancer multidrug resistance by modulation of efflux pumps in tumor cells. J. Med. Chem. 59, 3549\u20133561 (2016).","journal-title":"J. Med. Chem."},{"key":"98645_CR36","doi-asserted-by":"crossref","unstructured":"Iraji, A. et al. Ugi adducts: design and synthesis of natural-based \u03b1-glucosidase inhibitors. Lett. Org. Chem. 19, 1084\u20131093 (2022).","DOI":"10.2174\/1570178619666220401143634"},{"key":"98645_CR37","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1111\/febs.12503","volume":"280","author":"JL Ou","year":"2013","unstructured":"Ou, J. L. et al. Structure\u2013activity relationship analysis of curcumin analogues on anti-influenza virus activity. FEBS J. 280, 5829\u20135840 (2013).","journal-title":"FEBS J."},{"key":"98645_CR38","first-page":"1799","volume":"28","author":"M Correia-Da-Silva","year":"2023","unstructured":"Correia-Da-Silva, M. et al. Synthesis and characterization of curcumin-chitosan loaded gold nanoparticles by Oryctes rhinoceros\u2019 chitin for cosmeceutical application. Mol. 2023. 28, 1799 (2023).","journal-title":"Mol. 2023"},{"key":"98645_CR39","doi-asserted-by":"crossref","unstructured":"Arshad L. et al. Immunosuppressive Effects of Natural \u03b1,\u03b2-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review. Front. Pharmacol. 8, 1\u201322 (2017).","DOI":"10.3389\/fphar.2017.00022"},{"key":"98645_CR40","first-page":"706","volume":"19","author":"ZP HUO","year":"2021","unstructured":"HUO, Z. P., FENG, X. C., WANG, Y., TIAN, Y. T. & QIU, F. Sulfite as the substrate of C-sulfonate metabolism of \u0391, \u03b2-unsaturated carbonyl containing Andrographolide: analysis of sulfite in rats\u2019 intestinal tract and the reaction kinetics of Andrographolide with sulfite. Chin. J. Nat. Med. 19, 706\u2013712 (2021).","journal-title":"Chin. J. Nat. Med."},{"key":"98645_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/cmdc.200900499","volume":"5","author":"S Amslinger","year":"2010","unstructured":"Amslinger, S. The tunable functionality of \u03b1,\u03b2-Unsaturated carbonyl compounds enables their differential application in biological systems. ChemMedChem 5, 351\u2013356 (2010).","journal-title":"ChemMedChem"},{"key":"98645_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jpba.2011.05.029","volume":"56","author":"G Dowling","year":"2011","unstructured":"Dowling, G. & Malone, E. Analytical strategy for the confirmatory analysis of the non-steroidal anti-inflammatory drugs firocoxib, propyphenazone, ramifenazone and piroxicam in bovine plasma by liquid chromatography tandem mass spectrometry. J. Pharm. Biomed. Anal. 56, 359\u2013365 (2011).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"98645_CR43","unstructured":"Grima, M. et al. Mechanism of action of the diuretic effect of muzolimine. Archives des Maladies du Coeur et des Vaisseaux, 83, 1205\u20131208 (1990)."},{"key":"98645_CR44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.sjbs.2015.07.005","volume":"23","author":"R Surendra Kumar","year":"2016","unstructured":"Surendra Kumar, R., Arif, I. A., Ahamed, A. & Idhayadhulla, A. Anti-inflammatory and antimicrobial activities of novel pyrazole analogues. Saudi J. Biol. Sci. 23, 614\u2013620 (2016).","journal-title":"Saudi J. Biol. Sci."},{"key":"98645_CR45","doi-asserted-by":"crossref","unstructured":"Hosamani, K. M. & Chavan, R. R. Microwave-assisted synthesis, computational studies and antibacterial\/ anti-inflammatory activities of compounds based on coumarin-pyrazole hybrid. Royal Society open science. 5, 172435 (2018).","DOI":"10.1098\/rsos.172435"},{"key":"98645_CR46","doi-asserted-by":"crossref","unstructured":"Nehra, B. et al. Recent advancements in the development of bioactive pyrazoline derivatives.  European Journal of Medicinal Chemistry. 205, 112666 (2020).","DOI":"10.1016\/j.ejmech.2020.112666"},{"key":"98645_CR47","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/0006-2952(84)90547-1","volume":"33","author":"A Schmidt","year":"1984","unstructured":"Schmidt, A. et al. Influence of muzolimine on arterial wall Elastin. Biochem. Pharmacol. 33, 1915\u20131921 (1984).","journal-title":"Biochem. Pharmacol."},{"key":"98645_CR48","doi-asserted-by":"publisher","first-page":"S1409","DOI":"10.1016\/j.arabjc.2013.04.016","volume":"10","author":"MR Siddiqui","year":"2017","unstructured":"Siddiqui, M. R., AlOthman, Z. A. & Rahman, N. Analytical techniques in pharmaceutical analysis: A review. Arab. J. Chem. 10, S1409\u2013S1421 (2017).","journal-title":"Arab. J. Chem."},{"key":"98645_CR49","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1142\/S2737416521500344","volume":"20","author":"T Basak","year":"2021","unstructured":"Basak, T., Nath, V., Kumar, V. & Goyal, A. K. Silico identification of antifungal compounds as mutant DHFRase inhibitors: Structure-based approach, molecular dynamics simulation and structural integrity analysis. J. Comput. Biophys. Chem. 20, 589\u2013602 (2021).","journal-title":"J. Comput. Biophys. Chem."},{"key":"98645_CR50","doi-asserted-by":"publisher","first-page":"19385","DOI":"10.1021\/acs.jafc.3c05216","volume":"71","author":"R Feng","year":"2023","unstructured":"Feng, R. et al. Discovery of novel rhizoctonia Solani DHFR inhibitors as fungicides using virtual screening. J. Agric. Food Chem. 71, 19385\u201319395 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"98645_CR51","doi-asserted-by":"crossref","unstructured":"DeJarnette, C., Luna-Tapia, A., Estredge, L. R. & Palmer, G. E. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen Candida albicans. mSphere 5 (2020).","DOI":"10.1128\/mSphere.00374-20"},{"key":"98645_CR52","first-page":"e04212","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. N-Myristoyltransferase, a potential antifungal candidate drug-target for Aspergillus flavus. Microbiol. Spectr. 11, e04212\u2013e04222 (2022).","journal-title":"Microbiol. Spectr."},{"key":"98645_CR53","doi-asserted-by":"publisher","first-page":"137568","DOI":"10.1016\/j.molstruc.2024.137568","volume":"1303","author":"S Javid","year":"2024","unstructured":"Javid, S. et al. Rational design, synthesis, analysis and antifungal activity of novel myristic acid derivatives as N-myristoyltransferase inhibitors. J. Mol. Struct. 1303, 137568 (2024).","journal-title":"J. Mol. Struct."},{"key":"98645_CR54","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jscs.2014.12.004","volume":"20","author":"A Ahmad","year":"2016","unstructured":"Ahmad, A., Husain, A., Khan, S. A., Mujeeb, M. & Bhandari, A. Synthesis, antimicrobial and antitubercular activities of some novel pyrazoline derivatives antimicrobial and antitubercular activities of novel pyrazoline derivatives. J. Saudi Chem. Soc. 20, 577\u2013584 (2016).","journal-title":"J. Saudi Chem. Soc."},{"issue":"14","key":"98645_CR55","first-page":"1","volume":"141","author":"CS Yadav","year":"2024","unstructured":"Yadav, C. S. et al. Synthesis, characterization, quantum chemical modelling, molecular docking, in silico and in vitro assessment of 3-(2-bromo-5-fluorophenyl))-1-(thiophen-2-yl)prop-2-en-1-one. Sci. Rep.\u00a014, 29838\u00a0(2024).","journal-title":"Sci. Rep. 2024"},{"key":"98645_CR56","doi-asserted-by":"publisher","first-page":"9656","DOI":"10.1021\/acs.jafc.3c00578","volume":"71","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Insights into the antifungal properties of Myxobacteria outer membrane \u03b2-1,6-glucanase. J. Agric. Food Chem. 71, 9656\u20139666 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"98645_CR57","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution. In Ref. Method Broth Dilution Antifung Susceptibility Test. Yeasts Approv Stand. 3th ed. 28, 0\u201313 (2008)."},{"key":"98645_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1300\/J100v05n02_04","volume":"5","author":"ME Klepser","year":"2001","unstructured":"Klepser, M. E. et al. Multi-center evaluation of antifungal time-kill methods. J. Infect. Dis. Pharmacother. 5, 29\u201341 (2001).","journal-title":"J. Infect. Dis. Pharmacother"},{"key":"98645_CR59","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1093\/bioinformatics\/btaa160","volume":"36","author":"MM Hasan","year":"2020","unstructured":"Hasan, M. M. et al. HLPpred-Fuse: improved and robust prediction of hemolytic peptide and its activity by fusing multiple feature representation. Bioinformatics 36, 3350\u20133356 (2020).","journal-title":"Bioinformatics"},{"key":"98645_CR60","doi-asserted-by":"publisher","first-page":"100335","DOI":"10.1016\/j.comtox.2024.100335","volume":"32","author":"DA Karasev","year":"2024","unstructured":"Karasev, D. A., Malakhov, G. S. & Sobolev, B. N. Quantitative prediction of hemolytic activity of peptides. Comput. Toxicol. 32, 100335 (2024).","journal-title":"Comput. Toxicol."},{"key":"98645_CR61","first-page":"1","volume":"2017 71 7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017 71 7, 1\u201313 (2017).","journal-title":"Sci. Rep."},{"key":"98645_CR62","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","volume":"35","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. AdmetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35, 1067\u20131069 (2019).","journal-title":"Bioinformatics"},{"key":"98645_CR63","doi-asserted-by":"crossref","unstructured":"Azad, I., Khan, T., Ahmad, N., Khan, A. R. & Akhter, Y. Updates on drug designing approach through computational strategies: a review. Futur Sci. OA 9, (2023).","DOI":"10.2144\/fsoa-2022-0085"},{"key":"98645_CR64","doi-asserted-by":"crossref","unstructured":"Azad, I. Molecular docking in the study of ligand-protein recognition: an overview. Molecular Docking-Recent Advances, IntechOpen. (2023).","DOI":"10.5772\/intechopen.106583"},{"key":"98645_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-023-04269-1","volume":"24","author":"H Khan","year":"2024","unstructured":"Khan, H. et al. Structure based docking and biological evaluation towards exploring potential anti-cancerous and apoptotic activity of 6-gingerol against human prostate carcinoma cells. BMC Complement. Med. Ther. 24, 1\u201323 (2024).","journal-title":"BMC Complement. Med. Ther."},{"key":"98645_CR66","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"PC Agu","year":"2023","unstructured":"Agu, P. C. et al. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci. Rep. 13, 13398 (2023).","journal-title":"Sci. Rep."},{"key":"98645_CR67","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00249-022-01593-1","volume":"51","author":"M Pechlaner","year":"2022","unstructured":"Pechlaner, M., van Gunsteren, W. F., Hansen, N. & Smith, L. J. Molecular dynamics simulation or structure refinement of proteins: are solvent molecules required? A case study using hen lysozyme. Eur. Biophys. J. 51, 265\u2013282 (2022).","journal-title":"Eur. Biophys. J."},{"key":"98645_CR68","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1007\/s11030-022-10562-x","volume":"27","author":"SL Dhonnar","year":"2023","unstructured":"Dhonnar, S. L., Jagdale, B. S., Adole, V. A. & Sadgir, N. V. PEG-mediated synthesis, antibacterial, antifungal and antioxidant studies of some new 1,3,5-trisubstituted 2-pyrazolines. Mol. Divers. 27, 2441\u20132452 (2023).","journal-title":"Mol. Divers."},{"key":"98645_CR69","doi-asserted-by":"publisher","first-page":"254","DOI":"10.31351\/vol32issSuppl.pp254-261","volume":"32","author":"K Mervat Mohammed","year":"2023","unstructured":"Mervat Mohammed, K. & Omar, T. N. A. Synthesis characterization, anti-inflammatory, and antimicrobial evaluation of new 2-pyrazolines derivatives derived from guaiacol. Iraqi J. Pharm. Sci. 32, 254\u2013261 (2023).","journal-title":"Iraqi J. Pharm. Sci."},{"key":"98645_CR70","doi-asserted-by":"publisher","first-page":"499","DOI":"10.13005\/ojc\/400223","volume":"40","author":"SU Agare","year":"2024","unstructured":"Agare, S. U., More, M. P., Tajane, S. P. & Kadre, T. V. Synthesis, characterization and biological activity of novel heterocyclic compounds containing acylated pyrazoline. Orient. J. Chem. 40, 499\u2013505 (2024).","journal-title":"Orient. J. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98645-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:02:33Z","timestamp":1745816553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98645-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98645"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98645-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14752"}}